Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Sedana Medical AB's share price for the quarter that ended in Jun. 2026 was kr8.28. Sedana Medical AB's Shares Outstanding (EOP) for the quarter that ended in Jun. 2026 was 99.3 Mil. Therefore, Sedana Medical AB's market cap for the quarter that ended in Jun. 2026 was kr822.5 Mil.
Sedana Medical AB's quarterly market cap
declined
from Dec. 2025 (kr1,021.2 Mil) to Mar. 2026 (kr915.9 Mil) and
declined
from Mar. 2026 (kr915.9 Mil) to Jun. 2026 (kr822.5 Mil).
Sedana Medical AB's annual market cap
declined
from Dec. 2023 (kr2,300.6 Mil) to Dec. 2024 (kr1,895.3 Mil) and
declined
from Dec. 2024 (kr1,895.3 Mil) to Dec. 2025 (kr1,021.2 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Sedana Medical AB's Enterprise Value for Today is kr929.0 Mil.
Sedana Medical AB (OSTO:SEDANA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Sedana Medical AB Market Cap Related Terms
Sedana Medical AB Market Cap Historical Data
* Premium members only.
The historical data trend for Sedana Medical AB's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:SEDANA vs ABT, SYK, MDT: Market Cap Comparison
For the Medical Devices subindustry, Sedana Medical AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sedana Medical AB Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sedana Medical AB's Market Cap distribution charts can be found below:
* The bar in red indicates where Sedana Medical AB's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Sedana Medical AB's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sedana Medical AB (OSTO:SEDANA) has a Market Cap of kr973.5 Mil as of Aug. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sedana Medical AB and its competitors. According to the industry distribution chart, Sedana Medical AB ranks #451 out of 863 companies in the Medical Devices & Instruments industry, placing it in the top 52.3%.
Is Sedana Medical AB's Market Cap too high?
Sedana Medical AB's current Market Cap is kr973.5 Mil. Based on the distribution chart, Sedana Medical AB ranks #451 out of 863 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Sedana Medical AB has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sedana Medical AB's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sedana Medical AB ranks #451 out of 863 companies for Market Cap. This places Sedana Medical AB in the lower half of its industry. The industry median Market Cap is 112.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 112.48, based on 863 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sedana Medical AB and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 112.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sedana Medical AB's current Market Cap is kr973.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sedana Medical AB stock overvalued right now?
Based on GuruFocus' analysis, Sedana Medical AB (OSTO:SEDANA) is currently considered Significantly Undervalued. The stock's GF Value™ is kr17.42, compared to a current price of kr9.80 — trading 43.7% below its estimated fair value. The current Market Cap is kr973.5 Mil. Sedana Medical AB's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Sedana Medical AB (OSTO:SEDANA), the current Market Cap is kr973.5 Mil as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sedana Medical AB (OSTO:SEDANA) Overvalued in 2026?
Based on GuruFocus' analysis, Sedana Medical AB stock appears to be undervalued.
The current stock price of kr9.80 is trading 43.7% below its estimated GF Value™ of kr17.42.
GuruFocus considers Sedana Medical AB to be Significantly Undervalued.
Key valuation signals for OSTO:SEDANA:
Market Cap: kr973.5 Mil
GF Value™: kr17.42 vs. price of kr9.80 (43.7% below fair value)
No single metric tells the full story. See the OSTO:SEDANA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sedana Medical AB is a Sweden-based medical technology company. It is ais a pioneer medtech and pharmaceutical company focused on inhaled sedation to improve the patient's life during and beyond sedation. Through the combined strengths of the medical device Sedaconda ACD and the pharmaceutical Sedaconda (isoflurane), Sedana Medical provides inhaled sedation for mechanically ventilated patients in intensive care. Sedana Medical has direct sales in Benelux, France, Germany, Great Britain, and Spain. In other parts of Europe, as well as in Asia, Australia, Canada, and South and Central America, the company works with external distributors.
69GF Score
Get the complete analysis for OSTO:SEDANA
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:SEDANA has been successfully added to your 
